Invention Grant
- Patent Title: Metal oxide nanoparticle-based magnetic resonance imaging contrast agent with a central cavity
-
Application No.: US16943326Application Date: 2020-07-30
-
Publication No.: US11324841B2Publication Date: 2022-05-10
- Inventor: Kwang Yeol Lee , Min Sik Kim , Taek Hoon Kim , Ngoc Phan Vu
- Applicant: INTRON BIOTECHNOLOGY, INC.
- Applicant Address: KR Gyeonggi-do
- Assignee: INTRON BIOTECHNOLOGY, INC.
- Current Assignee: INTRON BIOTECHNOLOGY, INC.
- Current Assignee Address: KR Gyeonggi-do
- Agency: von Briesen & Roper, s.c.
- Main IPC: A61K49/18
- IPC: A61K49/18 ; B01J20/06 ; B01J20/28 ; B01J23/889 ; B01J35/00 ; H01M4/36 ; H01M4/50 ; H01M4/52 ; H01M4/86 ; H01M4/90
Abstract:
The present invention relates to a magnetic resonance imaging (MRI) contrast agent, particularly an MRI contrast agent derived from nanoparticle that is porous first metal-doped second metal oxide nanoparticle with a central cavity, and a method for producing the same. The MEI contrast agent made in accordance with the present invention can be used not only as a drug-delivery agent for therapy but also as an MRI contrast agent for diagnosis.
Public/Granted literature
- US20210008228A1 Metal Oxide Nanoparticle-Based Magnetic Resonance Imaging Contrast Agent with a Central Cavity Public/Granted day:2021-01-14
Information query
